Navigation Links
Biogenerics Legislation Provides Critical Pathway to Affordable Access for Patients with Chronic and Complex Conditions
Date:3/12/2009

WASHINGTON, March 12 /PRNewswire-FirstCall/ -- Proposed legislation that creates a regulatory framework to guide the approval of the first biogeneric medicines represents a critical step forward in providing more affordable treatment for millions of Americans suffering from chronic and complex conditions, David B. Snow Jr., chairman and CEO of Medco Health Solutions, Inc. (NYSE: MHS) said today.

"The investment in research and innovation over a period of many years has led to the breakthrough therapies that are available today in specialty pharmacy for the treatment of many serious diseases," said Snow. "We salute the vision of Chairman Waxman, Representative Deal and their co-sponsors, who have crafted an approach that balances the government's role for promulgating and regulating, while allowing the private sector to innovate and operate. This framework authorizes the FDA to construct an approval process that can lead to lower costs for payors and patients, while continuing to incent and reward breakthrough science."

Currently, as much as 16 percent of overall spending on so-called "specialty" medicines goes toward purchasing biotech drugs that have already lost their patent protection but, without this critical approval process, have no lower-cost generic competition. Medco estimates that generic versions of biotech medicines -- often called "biosimilars"-- could reach the market by 2013, creating a $34 billion opportunity in this new market through 2017, and significantly lowering the costs for these medicines.

"This legislation provides the FDA with the authority to ensure that we remain the world's gold standard for prescription drug safety, and extends it to a generics approval process for a new class of medicines," said Snow. "For all their therapeutic benefit, patients and payors alike are overwhelmed
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. GPhA Statement on the Introduction of the Bipartisan Biogenerics Consensus Bill: Promoting Innovation and Access to Life-Saving Medicine Act
2. Hospira Supports Newly Introduced Biogenerics Legislation
3. CBO: Biogenerics Would Save Federal Government $6.6 Billion Over Ten Years
4. Coalition for a Competitive Pharmaceutical Market Launches New Print Ad Campaign Highlighting Need for Meaningful Biogenerics Legislation
5. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
6. Biogenerics Will Save Billions, Says Hospira CEO
7. Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers
8. Teva Applauds Historic Biotech Competition Legislation
9. Netsmart Technologies Web Seminar Helps Behavioral Health Organizations Understand Electronic Prescribing and the Importance of New Medicare-Related E-Prescribing Legislation
10. AstraZeneca Supports Transparency Legislation on Payments to Health Care Providers
11. Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC ... Pharmaceutical Holding Company Limited (Biohaven), announced today that ... of BHV-0223, a glutamate modulating agent. Biohaven filed ... recently obtained clearance from the U.S. Food and ... Portage holds 54% equity interest in Biohaven, a ...
(Date:8/27/2015)... GlassesOff (OTCBB: GLSO), a visual neuroscience ... human vision system, announced today a partnership with eight-time All-Star, ... Paul to develop a new mobile app designed for ... real-life on-court performance. Vision is the inception of ... a ball or blocking a pass. The critical impact vision ...
(Date:8/26/2015)... Manhattan, KS (PRWEB) , ... August 26, 2015 ... ... & Biologic Solutions, announces today that a second US laboratory is to open ... in accordance with the continued partnership and long-term growth of research and development ...
(Date:8/26/2015)... Aug. 26, 2015  Platform therapeutic company Symic ... received a $1.5M Phase II SBIR grant from ... develop its therapeutic agent to reduce arteriovenous fistula ... end stage renal disease (ESRD) patients undergoing hemodialysis. ... of Diabetes and Digestive and Kidney Diseases (NIDDK), ...
Breaking Biology Technology:Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3
... Calif., Feb. 2 IPC The Hospitalist Company, Inc. (Nasdaq: IPCM ), a leading national physician group ... Conference held in Naples, FL. , , ... Speaker: ... Date: ...
... SAN DIEGO, Feb. 2 BioMed Realty Trust, Inc. (NYSE: ... for its fourth quarter and year ended December 31, 2008 ... D. Gold, Chairman and Chief Executive Officer, and Kent Griffin, ... call at 10:00 a.m. Pacific Time on Thursday, February 12, ...
... Cancer Advances, Inc. (Cancer Advances), a Cato BioVentures ... acquisition of all the technology and intellectual property for ... for application in three gastrointestinal cancers. Cancer Advances was ... to acquire products developed to inhibit the hormone, gastrin, ...
Cached Biology Technology:IPC The Hospitalist Company, Inc. to Present at Deutsche Bank 2009 Small and Mid Cap Conference 2BioMed Realty Trust to Report 2008 Fourth Quarter and Year-End Results 2Cancer Advances Acquires the Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic, and Colorectal Cancers 2Cancer Advances Acquires the Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic, and Colorectal Cancers 3
(Date:8/18/2015)... 17, 2015 Research and Markets ( ... "Global Biometric Authentication & Identification Market: Focus ... Forecast, 2015-2020" report to their offering. ... systems market is expected to grow at an ... and generate over $25 billion (approximately) by 2020 ...
(Date:8/12/2015)... Calif. , Aug. 12, 2015  Synaptics ... of human interface solutions, today announced that four ... announced Match-in-Sensor solution, have officially been named FIDO ... As part of the certification, Synaptics, Natural ID™ ... 1.0 Universal Authentication Framework (UAF) standard and are ...
(Date:8/6/2015)... TELTOW, Germany , August 6, 2015 ... SensoMotoric Instruments (SMI) shows the world,s first ... based on Epson,s Moverio BT-200 see-through head mounted ... this new solution, unprecedented quality and efficiency is brought ... context-sensitive displays. For the first time, professionals and researchers ...
Breaking Biology News(10 mins):Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3
... When forest biologist Claire Williams boards ferries bound for North ... coast, ferry captains call her the "Pollen Lady." ... forth from the islands to the mainland, collecting pine pollen ... from the loblolly pine the most commonly planted tree ...
... are often hamstrung by less-than-ideal grafting material when performing ... or cancer. Conventional synthetic bone grafts are typically made ... conform to the complex and irregular shapes that often ... fixation devices that require open surgeries to insert and ...
... -- Highly dangerous Cryptococcus fungi love sugar and ... particular, they thrive on a sugar called inositol ... To borrow inositol from a person,s brain, the fungi ... transporter molecules. While a typical fungus has just two such ...
Cached Biology News:Gone with the wind: Far-flung pine pollen still potent miles from the tree 2Smart orthopedic implants and self-fitting tissue scaffolding created by UMMS researchers 2This is your brain on Cryptococcus: Pathogenic fungus loves your brain sugar 2
... Studio Enterprise is integrated informatics solution ... mechanisms and drug response modeling. This ... worlds largest knowledge base of biological ... MedScan module capable of extracting pathway-related ...
... Rapid-Screen cDNA Library Panels were designed for ... sets of PCRs to identify the desired ... performed in a 96-well "Master Plate," where ... clones. Having identified the positive well(s) by ...
Application: For use as a carrier in nucleic acid purification and precipitation. Physical form: Solution in 10 mM Tris HCl, pH 7.4, 1 mM EDTA Concentration: 9-11 mg/mL Physical Form: buffered aqu...
... Preparation Note: Prepared by a modification ... et al., Biotechnol. Bioeng., ... One unit will yield an A ... ml of water (1 cm light ...
Biology Products: